Document is current
Any future updates will be listed below
-
Authors
Letian, Anudari
Lemma, Eyoel Yemanaberhan
Cavaliere, Paola
Dephoure, Noah
Altorki, Nasser K.
McGraw, Timothy E.
-
Funding
Funding for this research was provided by:
National Cancer Institute, United States (UG3 CA244697, UG3 CA244697, UG3 CA244697)
National Cancer Institute (USA) diversity supplement (CA244697)
- License Information
-
More Information
Article History
Received: 28 November 2022
Accepted: 14 February 2023
First Online: 13 March 2023
Declarations
:
: Human lung tumor tissue samples were obtained from surgically resected material at New York-Presbyterian-Weill Cornell Medicine. The study was approved by the New York-Presbyterian-Weill Cornell Medicine institutional review board and patient consent was received for these studies.
: The authors have no competing interests to disclose related to this study. NKA has equity in Angiocrine Bioscience. TEM receives research funding from Janssen and from Pfizer, Inc. The other authors have nothing to disclose.
